Fundraising FoxKolltan Pharmaceuticals
New Haven, US · Founded 2007 · 1 known investors
Find your way into Kolltan Pharmaceuticals
Sign up to see every warm intro you have to Kolltan Pharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Kolltan Pharmaceuticals team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Kolltan Pharmaceuticals was founded in 2007 by Joseph Schlessinger and Michael Schmertzler.
JS
Joseph SchlessingerCo-founder
SC
Stanley ChoyExecutive
YH
Yaron HadariExecutive
WB
W. Bradford MiddlekauffExecutive
Board
AB
Axel BolteBoard director
EJ
E. Jonathan SoderstromBoard director
AG
Arthur G. Altschul, Jr.Board director
KP
K. Peter HirthBoard director
TB
Thomas B. NeffBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$85M disclosed across 2 rounds · 2012–2014
▶$60MraisedMar 2014 · 34 investors · BiotechnologyRule 506(b)
▶$60MraisedMar 2014 · 34 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- E. Jonathan SoderstromDirector
- Axel BolteDirector
- Paul MedeirosDirector
- K. Peter HirthDirector
- Stanley ChoyExecutive Officer
- Yaron HadariExecutive Officer
- Theresa M. LaValleeExecutive Officer
- Joseph SchlessingerDirector
- Carolyn F. SidorExecutive Officer
- Gerald McMahonExecutive Officer, Director
- Thomas B. NeffDirector
- Arthur G. Altschul, Jr.Director
- Jane Pritchett HendersonExecutive Officer
- Offering amount
- $60M
- Amount sold
- $60M
- First sale
- Mar 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$25MraisedMar 2012 · 1 investors · BiotechnologyRule 506(b)
▶$25MraisedMar 2012 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Stanley ChoyExecutive Officer
- Axel BolteDirector
- E. Jonathan SoderstromDirector
- Yaron HadariExecutive Officer
- Joseph SchlessingerDirector
- Arthur G. Altschul, Jr.Director
- K. Peter HirthDirector
- Thomas B. NeffDirector
- Michael SchmertzlerExecutive Officer, Director
- W. Bradford MiddlekauffExecutive Officer
- Offering amount
- $25M
- Amount sold
- $25M
- First sale
- Mar 2012
- Incorporated
- Corporation, Delaware, 2007
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Kolltan Pharmaceuticals?
- Kolltan Pharmaceuticals was founded by Joseph Schlessinger, Michael Schmertzler in 2007.
- Who are Kolltan Pharmaceuticals's investors?
- Kolltan Pharmaceuticals's investors include OUP (Osage University Partners).
- How much funding has Kolltan Pharmaceuticals raised?
- Kolltan Pharmaceuticals has disclosed $85M raised across 2 rounds.
- Where is Kolltan Pharmaceuticals headquartered?
- Kolltan Pharmaceuticals is headquartered in New Haven, US.